First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors

Summary

Analysis of safety, tolerability, and PK data will provide information that will guide future development of AB0024.

Timeline

Start

2010-06

Primary completion

2012-03

Completion

2012-03

Publications

• Barker HE, Cox TR, Erler JT. The rationale for targeting the LOX family in cancer. Nat Rev Cancer. 2012 Jul 19;12(8):540-52. doi: 10.1038/nrc3319.

Drugs

Indications